We are live on !
Find out more
Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
(+16%)
Cap. Flow
+$6.93B
Cap. Flow % of AUM
Cap. Flow %
4.05%
Top 10 Holdings %
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133
Avg Time Held
Equity + Options
4.2
years
Top 10 Avg Time Held
Equity + Options
1.7
years
Top 20 Avg Time Held
Equity + Options
4.3
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
4.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$682M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$526M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$431M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$239M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$74.4M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$41.1M |
| 4 |
Honeywell
HON
|
+$39.3M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.8% |
| 2 | Technology | 9.57% |
| 3 | Financials | 3.79% |
| 4 | Industrials | 2.49% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2301
Pitney Bowes
PBI
$2.38B
| $1.55M | ﹤0.01% |
88,446
+70,596
| +395% | +$1.08M |
2025 Q1
5 quarters
|
|
2302
First Trust Cloud Computing ETF
SKYY
$3.47B
| $1.55M | ﹤0.01% |
11,509
-854
| -7% | -$109K |
2015 Q3
43 quarters
|
|
2303
Columbus McKinnon
CMCO
$390M
| $1.54M | ﹤0.01% |
102,063
-35,157
| -26% | -$524K |
2024 Q3
7 quarters
|
|
2304
Cimpress
CMPR
$1.96B
| $1.54M | ﹤0.01% |
15,150
+463
| +3% | +$41.1K |
2024 Q1
9 quarters
|
|
2305
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$5.72B
| $1.54M | ﹤0.01% |
15,970
-2,613
| -14% | -$252K |
2021 Q3
19 quarters
|
|
2306
The GEO Group
GEO
$3.6B
| $1.54M | ﹤0.01% |
52,054
+18,052
| +53% | +$409K |
2024 Q2
8 quarters
|
|
2307
Marcus & Millichap
MMI
$1.04B
| $1.54M | ﹤0.01% |
49,329
+9,100
| +23% | +$261K |
2024 Q2
8 quarters
|
|
2308
Alignment Healthcare
ALHC
$1.67B
| $1.54M | ﹤0.01% |
64,527
-44,974
| -41% | -$863K |
2024 Q2
8 quarters
|
|
2309
UiPath
PATH
$7.36B
| $1.53M | ﹤0.01% |
140,610
-45,135
| -24% | -$482K |
2021 Q2
20 quarters
|
|
2310
Dole
DOLE
$1.27B
| $1.53M | ﹤0.01% |
111,306
-33,542
| -23% | -$488K |
2024 Q4
6 quarters
|
|
2311
Mine Safety
MSA
$7.03B
| $1.52M | ﹤0.01% |
8,731
+1,194
| +16% | +$200K |
2023 Q2
12 quarters
|
|
2312
Enphase Energy
ENPH
$4.18B
| $1.52M | ﹤0.01% |
30,930
-9,737
| -24% | -$444K |
2018 Q1
33 quarters
|
|
2313
Lemonade
LMND
$3.48B
| $1.52M | ﹤0.01% |
23,403
-3,050
| -12% | -$178K |
2024 Q4
6 quarters
|
|
2314
Calumet Specialty Products
CLMT
$4.33B
| $1.51M | ﹤0.01% |
42,053
-1,686
| -4% | -$56.7K |
2013 Q2
52 quarters
|
|
2315
RadNet
RDNT
$5.54B
| $1.51M | ﹤0.01% |
24,560
-13,179
| -35% | -$741K |
2024 Q2
8 quarters
|
|
2316
DELISTED
Crinetics Pharmaceuticals
CRNX
| $1.51M | ﹤0.01% |
40,476
-13,161
| -25% | -$489K |
2024 Q1
9 quarters
|
|
2317
QXO Inc
QXO
$10.9B
| $1.51M | ﹤0.01% |
87,474
-6,404
| -7% | -$119K |
2025 Q2
4 quarters
|
|
2318
Defiance Space and Connective Tech ETF
UFOX
$805M
| $1.51M | ﹤0.01% |
15,888
-134
| -0.8% | -$11.9K |
2020 Q2
24 quarters
|
|
2319
Caesars Entertainment
CZR
$5.87B
| $1.51M | ﹤0.01% |
49,888
-9,138
| -15% | -$258K |
2022 Q3
15 quarters
|
|
2320
Bloomin' Brands
BLMN
$788M
| $1.51M | ﹤0.01% |
164,719
+66,377
| +67% | +$483K |
2024 Q3
7 quarters
|
|
2321
Fidelity MSCI Financials Index ETF
FNCL
$2.31B
| $1.5M | ﹤0.01% |
19,566
+3,286
| +20% | +$243K |
2021 Q3
19 quarters
|
|
2322
Oruka Therapeutics
ORKA
$5.31B
| $1.5M | ﹤0.01% |
15,738
+3,002
| +24% | +$200K |
2025 Q4
2 quarters
|
|
2323
Xenon Pharmaceuticals
XENE
$3.42B
| $1.5M | ﹤0.01% |
24,805
-5,013
| -17% | -$278K |
2025 Q3
3 quarters
|
|
2324
Collegium Pharmaceutical
COLL
$747M
| $1.5M | ﹤0.01% |
41,341
+11,703
| +39% | +$400K |
2024 Q1
9 quarters
|
|
2325
Innovator US Equity Power Buffer ETF January
PJAN
$1.42B
| $1.5M | ﹤0.01% |
30,237
+4,442
| +17% | +$216K |
2026 Q1
1 quarter
|
|
Similar funds
Creative Planning's Q2 2026 Portfolio in Review
As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.
- Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
- Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
- Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
- Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
- Creative Planning opened 337 new positions and closed 133 in Q2 2026.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.